AIHealthcare

Ginkgo Bioworks (NYSE: DNA) is a synthetic biology and "bio × AI" company that builds autonomous laboratories and data platforms to program cells and generate high‑throughput biological datasets for applications across healthcare, drug discovery, biosecurity, and industrial biotechnology. The company integrates robotics, automation, and machine learning to design custom microbes, engineer proteins, and produce large‑scale perturbation and ADME/Tox datasets that power AI models in therapeutics, target discovery, and pharmacology. Through its R&D Solutions, Datapoints data business, and autonomous lab infrastructure (e.g., the Nebula lab and Virtual Cell Pharmacology Initiative), Ginkgo positions itself as a horizontal platform enabling pharma, biotech, and AI partners to accelerate discovery and development using AI‑driven experimental design and cloud‑accessible robotic labs.